Decreased expressions of hepsin in human hepatocellular carcinomas

Liver International

Volumn 26, Issue 7, 2006, Pages 774-780

  Chen, Chien Hung ^a   Su, Kang Yi ^a   Tao, Mi Hua ^a   Lin, Shu Wha ^a   Su, Ying Hui ^a   Tsai, Yu Chiu ^a   Cheng, Kuang Chun ^a   Jeng, Yung Ming ^a   Sheu, Jin Chuan ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hepatitis B virus; Hepatocellular carcinoma; Hepsin; Prognosis; Real time quantitative PCR

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HEPSIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; FATALITY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; SURVIVAL ANALYSIS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 33746749934     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01307.x     Document Type: Article

References (22)

1. Chen D S. Hepatitis B virus infection, its sequelae, and prevention in Taiwan. In: Okuda K, Ishak KG, eds. Neoplasms of the Liver. Tokyo: Springer-Verlag, 1987; 71-80.
2. Thorgeirsson S S, Grisham J W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339-46.
3. Kurachi K, Torres-Rosado A, Tsuji A. Hepsin. Methods Enzymol 1994; 244: 100-14.
4. Leytus S P, Loeb K R, Hagen F S, Kurachi K, Davie E W. A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry 1988; 27: 1067-74.
5. Somoza J R, Ho J D, Luong C, et al. The structure of the extracellular region of human hepsin reveals a serine protease domain and a novel scavenger receptor cysteine-rich (SRCR) domain. Structure 2003; 11: 1123-31.
6. Tsuji A, Torres-Rosado A, Arai T, et al. Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. J Biol Chem 1991; 266: 16948-53.
7. Tanimoto H, Yan Y, Clarke J, et al. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res 1997; 57: 2884-7.
8. Wu Q, Yu D, Post J, Halks-Miller M, Sadler J E, Morser J. Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. J Clin Invest 1998; 101: 321-6.
9. Yu I S, Chen H J, Lee Y S, et al. Mice deficient in hepsin, a serine protease, exhibit normal embryogenesis and unchanged hepatocyte regeneration ability. Thromb Haemost 2000; 84: 865-70.
10. Zacharski L R, Ornstein D L, Memoli V A, Rousseau S M Kisiel W. Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma. Thromb Haemost 1998; 79: 876-7.
11. Magee J A, Araki T, Patil S, et al. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 2001; 61: 5692-6.
12. Dhanasekaran S M, Barrette T R, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001; 412: 822-6.
13. Welsh J B, Sapinoso L M, Su A I, et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001; 61: 5974-8.
14. Luo J, Duggan D J, Chen Y, et al. Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling. Cancer Res 2001; 61: 4683-8.
15. Stephan C, Yousef G M, Scorilas A, et al. Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. J Urol 2004; 171: 187-91.
16. Kazama Y, Hamamoto T, Foster D C, Kisiel W. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J Biol Chem 1995; 270: 66-72.
17. Srikantan V, Valladares M, Rhim J S, Moul J W, Srivastava S. HEPSIN inhibits cell growth/invasion in prostate cancer cells. Cancer Res 2002; 62: 6812-6.
18. Roemer A, Schwettmann L, Jung M, et al. The membrane proteases adams and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers? J Urol 2004; 172: 2162-6.
19. Klezovitch O, Chevillet J, Mirosevich J, Roberts R L, Matusik R J, Vasioukhin V. Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 2004; 6: 185-95.
20. Xuan J A, Schneider D, Toy P, et al. Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture. Cancer Res 2006; 66: 3611-9.
21. Zhang J L, Zhao W G, Wu K L, et al. Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease Hepsin. Arch Virol 2005; 150: 721-41.
22. Chung T W, Lee Y C, Ko J H, Kim C H. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells. Cancer Res 2003; 63: 3453-8.